Emicizumab

Last Updated: 02/24/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 800 publications

Redefining hemophilia management: treatment goals, nonfactor replacement therapies, and the role of fitusiran.

Redefining hemophilia management: treatment goals, nonfactor replacement therapies, and the role of fitusiran.

Journal: The American journal of managed care

Published: January 21, 2026

Emicizumab in Acquired Hemophilia A: A Real-World Case Series with Patient-Level Outcome Analysis.

Emicizumab in Acquired Hemophilia A: A Real-World Case Series with Patient-Level Outcome Analysis.

Journal: Seminars in thrombosis and hemostasis

Published: January 14, 2026

Physical Activity in People with Hemophilia.

Physical Activity in People with Hemophilia.

Journal: Seminars in thrombosis and hemostasis

Published: December 26, 2025

Recurrence of FVIII Inhibitor during Surgery in a Patient with Severe Hemophilia A Receiving Emicizumab Prophylaxis.

Recurrence of FVIII Inhibitor during Surgery in a Patient with Severe Hemophilia A Receiving Emicizumab Prophylaxis.

Journal: Acta medica Okayama

Published: December 24, 2025

Therapeutic Antibodies in Hematology: Advances in Malignant and Non-Malignant Disorders.

Therapeutic Antibodies in Hematology: Advances in Malignant and Non-Malignant Disorders.

Journal: Cells

Published: December 02, 2025

Evaluation of Autoimmune FVIII Inhibitor Using Clot Waveform Analysis in Emicizumab-Treated Patients.

Evaluation of Autoimmune FVIII Inhibitor Using Clot Waveform Analysis in Emicizumab-Treated Patients.

Journal: Journal of clinical medicine

Published: November 27, 2025

Comparative safety of drug therapies used in hemophilia A and B in Canada: a multi-center, retrospective study.

Comparative safety of drug therapies used in hemophilia A and B in Canada: a multi-center, retrospective study.

Journal: Research and practice in thrombosis and haemostasis

Published: October 29, 2025

NuPOWER (Nuwiq for Perioperative management Of patients With haemophilia A on Emicizumab Regular prophylaxis): protocol for an open-label, single-arm, multicentre study.

NuPOWER (Nuwiq for Perioperative management Of patients With haemophilia A on Emicizumab Regular prophylaxis): protocol for an open-label, single-arm, multicentre study.

Journal: BMJ open

Published: October 28, 2025

Outcomes of Emicizumab Treatment for Haemophilia A Paediatric Patients: A Systematic Review With Meta-Analysis.

Outcomes of Emicizumab Treatment for Haemophilia A Paediatric Patients: A Systematic Review With Meta-Analysis.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: October 24, 2025

Laboratory Monitoring in Patients Receiving Emicizumab.

Laboratory Monitoring in Patients Receiving Emicizumab.

Journal: Hamostaseologie

Published: October 09, 2025

Repeated hemorrhagic ulcers of the esophagus associated with acquired hemophilia A: A case report.

Repeated hemorrhagic ulcers of the esophagus associated with acquired hemophilia A: A case report.

Journal: World journal of gastrointestinal endoscopy

Published: September 29, 2025

Laboratory Assessment of Emicizumab Levels in Hemophilia A: Influence of Assay Selection on Reported Results.

Laboratory Assessment of Emicizumab Levels in Hemophilia A: Influence of Assay Selection on Reported Results.

Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

Published: September 26, 2025

Showing 1-12 of 800

Last Updated: 02/24/2026